Female Pattern Alopecia: Its Importance in Medicine and Aesthetic Surgery

The study "Alopecia con patrón femenino. Su importancia en medicina y cirugía estética" from June 15, 2020, investigated female pattern hair loss (FPHL), a common condition affecting 29% to 38% of pre-menopausal women and over 55% of women over 70. The cause of FPHL is believed to be multifactorial, with hormonal and genetic factors playing a significant role. The study emphasized the importance of early diagnosis and treatment to prevent progression, with topical Minoxidil being the only FDA-approved treatment at the time. The document also explored various other treatments, including low-intensity laser treatment, Finasteride, Dutasteride, and others, but concluded that more double-blind randomized studies are needed to establish their effectiveness. The psychological impact of FPHL, including anxiety, depression, and low self-esteem, was also highlighted.